公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2023 | Halfway through HBV elimination - are we not waiting? | Wong, Grace Lai-Hung; Ong, Janus P; Kaewdech, Apichat; TUNG-HUNG SU | International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | | | |
2024 | HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; Chiang, Chieh; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; JIA-HORNG KAO | JHEP reports : innovation in hepatology | | | |
2010 | HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses | Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; CHI-LING CHEN ; JIA-HORNG KAO ; Lai M.-Y.; CHEN-HUA LIU ; TUNG-HUNG SU ; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; PEI-JER CHEN ; CHUN-JEN LIU ; DING-SHINN CHEN | Journal of Infectious Diseases | 42 | 37 | |
2015 | HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients | Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Lin H.H.; Wang C.-C.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 12 | 11 | |
2018 | HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed? | TUNG-HUNG SU ; TAI-CHUNG TSENG ; JIA-HORNG KAO | Hepatology | 11 | 10 | |
2022 | Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate Phase | TAI-CHUNG TSENG ; Hosaka, Tetsuya; CHUN-JEN LIU ; Suzuki, Fumitaka; CHUN-MING HONG ; Kumada, Hiromitsu; Yang, Wan-Ting; Hsu, Chen-Yang; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; HSIU-HSI CHEN ; JIA-HORNG KAO | The American journal of gastroenterology | 14 | 12 | |
2024 | Hepatitis B reactivation: A possible cause of coronavirus disease 2019 vaccine induced hepatitis | Wu, Hsin-Yun; TUNG-HUNG SU ; CHUN-JEN LIU ; HUNG-CHIH YANG ; JIA-HUEI TSAI ; Wei, Ming-Han; CHIEH-CHANG CHEN ; CHIEN-CHIH TUNG ; JIA-HORNG KAO ; PEI-JER CHEN | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2014 | Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 13 | 9 | |
2016 | Hepatitis B surface antigen loss and hepatocellular carcinoma development in patients with dual hepatitis B and C infection | Yang W.-T.; Wu L.-W; TAI-CHUNG TSENG ; CHI-LING CHEN ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHUN-JEN LIU ; JIA-HORNG KAO | Medicine (United States) | 20 | 15 | |
2020 | Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era | Chieh-Lung Cheng ; Huang, Sheng-Chuan; Chen, Jia-Hong; Wei, Chao-Hung; Fang, Wei-Quan; TUNG-HUNG SU ; CHANG-TSU YUAN ; JIA-HAU LIU ; MING-KAI CHUANG ; HWEI-FANG TIEN | The oncologist | 10 | 10 | |
2017 | Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infection | CHEN-HUA LIU ; CHUN-JEN LIU ; TUNG-HUNG SU ; YU-JEN FANG ; HUNG-CHIH YANG ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Open Forum Infectious Diseases | 42 | 39 | |
2018 | Hepatitis b virus–specific t cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation | Rivino L.; Le Bert N.; Gill U.S.; Kunasegaran K.; Cheng Y.; Tan D.Z.M.; Becht E.; Hansi N.K.; Foster G.R.; TUNG-HUNG SU ; TAI-CHUNG TSENG ; Lim S.G.; JIA-HORNG KAO ; Newell E.W.; Kennedy P.T.F.; Bertoletti A. | Journal of Clinical Investigation | 157 | 145 | |
2016 | Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study | TUNG-HUNG SU ; CHUN-JEN LIU ; TAI-CHUNG TSENG ; Chou S.-W; CHEN-HUA LIU ; HUNG-CHIH YANG ; SHANG-JU WU ; PEI-JER CHEN ; DING-SHINN CHEN ; CHI-LING CHEN ; JIA-HORNG KAO | Hepatology | 35 | 31 | |
2022 | Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment | CHEN-HUA LIU ; Peng, Cheng-Yuan; Kao, Wei-Yu; Yang, Sheng-Shun; Shih, Yu-Lueng; CHIH-YUAN LEE ; MENG-KUN TSAI ; Lee, Chih-Yuan; Chang, Chun-Chao; Wu, Jo-Hsuan; CHUN-JEN LIU ; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO | Alimentary pharmacology & therapeutics | 11 | 9 | |
2022 | Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study | CHEN-HUA LIU ; HSIN-YUN SUN ; Peng, Cheng-Yuan; SZU-MIN HSIEH ; Yang, Sheng-Shun; Kao, Wei-Yu; Shih, Yu-Lueng; Lin, Chih-Lin; CHUN-JEN LIU ; WANG-HUEI SHENG ; Lo, Yi-Chun; Liu, Wen-Chun; Wu, Jo-Hsuan; TUNG-HUNG SU ; TAI-CHUNG TSENG ; PEI-JER CHEN ; CHIEN-CHING HUNG ; JIA-HORNG KAO | Open forum infectious diseases | 9 | 7 | |
2022 | Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study | Papatheodoridi, Margarita; TUNG-HUNG SU ; Hadziyannis, Emilia; Liao, Chun-Hsun; Orfanidou, Αfroditi; HUNG-CHIH YANG ; Zachou, Kalliopi; CHUN-JEN LIU ; Kourikou, Anastasia; Gatselis, Nikolaos; Manolakopoulos, Spilios; Dalekos, George; JIA-HORNG KAO ; Hadziyannis, Stephanos; Papatheodoridis, George V | Liver international : official journal of the International Association for the Study of the Liver | 8 | 7 | |
2020 | HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Chang C.T; TUNG-HUNG SU ; Yang W.-T; Tsai C.-H; CHI-LING CHEN ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Hepatology | 41 | 32 | |
2019 | High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; Hsu C.-Y; CHUN-MING HONG ; TUNG-HUNG SU ; Yang W.-T; CHI-LING CHEN ; HUNG-CHIH YANG ; Huang Y.-T; Fang-Tzu Kuo S; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 94 | 76 | |
2012 | High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load | TAI-CHUNG TSENG ; CHUN-JEN LIU ; HUNG-CHIH YANG ; TUNG-HUNG SU ; Wang C.-C; CHI-LING CHEN ; Kuo S.F.-T; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Gastroenterology | 430 | 381 | |
2020 | High risk of clinical relapse in patients with chronic Hepatitis B virus infection after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy | Chang W.-Y.; Chiu Y.-C; Chiu F.-W; Hsu Y.-C; TAI-CHUNG TSENG ; Cheng P.-N; Yang S.-S; CHUN-JEN LIU ; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Infectious Diseases | 5 | 5 | |